Figure 5.
Ischemic stroke—sequential analysis of new users of DOACs vs VKAs—HR and 95% CI. CI indicates confidence interval; DOAC, direct oral anticoagulants; HR, hazard ratio; PS, propensity score; VKA, vitamin K antagonists.
Ischemic stroke—sequential analysis of new users of DOACs vs VKAs—HR and 95% CI. CI indicates confidence interval; DOAC, direct oral anticoagulants; HR, hazard ratio; PS, propensity score; VKA, vitamin K antagonists.